• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Isolation and properties of methotrexate-resistant choriocarcinoma cells in vitro].

作者信息

Kaiho T, Sekiya S, Shirotake S, Takamizawa H

出版信息

Nihon Sanka Fujinka Gakkai Zasshi. 1984 Dec;36(12):2517-24.

PMID:6542932
Abstract

The sensitivity to methotrexate (MTX) of ten kinds of human choriocarcinoma cell lines was studied in vitro. The cell line most sensitive to MTX was HCCM-5 and it was fed with a medium containing increasing concentrations of MTX. A resistant subline (HCCM-5R) which could proliferate in the medium containing 5 X 10(-7)M MTX was obtained after about 80 weeks of feeding. The properties of HCCM-5R cells were compared with those of the parent HCCM-5 cells. i) There were no apparent differences in morphology between the HCCM-5 and HCCM-5R lines. The population doubling time was almost the same for both cell lines. ii) The hCG level in the culture fluid of the HCCM-5R cells was about twice as high as that of the HCCM-5 cells. iii) The concentration of MTX which inhibited 50% of DNA synthesis in HCCM-5R cells was 10,000 times higher than that for HCCM-5 cells. iv) Each X and Y chromosome was identified in 90% of the HCCM-5 cells, while no Y chromosome was detected in the HCCM-5R cells. v) The DNA distribution pattern for HCCM-5R cells consisted of a large fraction of each cell with DNA G1 phase content and distributed in the tetraploid range, whereas that of HCCM-5 showed no particular cell cycle pattern. vi) The incorporation of 3H-MTX in the HCCM-5R cells was one tenth of that in the HCCM-5. vii) The intracellular DHFR activity of the HCCM-5R cells was about 5 times higher than that of HCCM-5. These results suggest that MTX-resistant cells among the HCCM-5 cells were selected in long-term contact with MTX, and sensitivity to MTX was concerned with both the MTX transport and intracellular DHFR levels.

摘要

相似文献

1
[Isolation and properties of methotrexate-resistant choriocarcinoma cells in vitro].
Nihon Sanka Fujinka Gakkai Zasshi. 1984 Dec;36(12):2517-24.
2
Development of methotrexate-resistant human choriocarcinoma cells in culture.培养耐甲氨蝶呤的人绒毛膜癌细胞
Gynecol Oncol. 1985 May;21(1):46-53. doi: 10.1016/0090-8258(85)90231-8.
3
[Characterization of two choliocarcinoma cell lines and their sensitivity to MTX].[两种胆管癌细胞系的特征及其对甲氨蝶呤的敏感性]
Nihon Sanka Fujinka Gakkai Zasshi. 1983 Jan;35(1):1-9.
4
[MTX sensitivity and the mechanism of resistance of various choriocarcinoma cells in culture].[培养的各种绒毛膜癌细胞的甲氨蝶呤敏感性及耐药机制]
Nihon Sanka Fujinka Gakkai Zasshi. 1983 Sep;35(9):1611-6.
5
[Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].[绒毛膜癌细胞对甲氨蝶呤耐药性的产生机制]
Hokkaido Igaku Zasshi. 1986 Sep;61(5):649-61.
6
[Analysis of cytotoxicity in cultured choriocarcinoma cell lines using methotrexate and actinomycin-D].[使用甲氨蝶呤和放线菌素-D对培养的绒毛膜癌细胞系进行细胞毒性分析]
Nihon Sanka Fujinka Gakkai Zasshi. 1983 Sep;35(9):1641-8.
7
[MTX resistant mechanisms in human choriocarcinoma cells].[人绒毛膜癌细胞中的甲氨蝶呤耐药机制]
Nihon Sanka Fujinka Gakkai Zasshi. 1987 May;39(5):807-14.
8
[Establishment of methotrexate-resistant human gestational choriocarcinoma cells in culture and analysis of mechanism of resistance].[培养甲氨蝶呤耐药的人绒毛膜癌细胞并分析耐药机制]
Nihon Sanka Fujinka Gakkai Zasshi. 1984 Nov;36(11):2129-37.
9
Effect of methotrexate on the growth and human chorionic gonadotropin secretion of human choriocarcinoma cell lines in vitro.甲氨蝶呤对人绒毛膜癌细胞系体外生长及人绒毛膜促性腺激素分泌的影响。
Am J Obstet Gynecol. 1983 May 1;146(1):57-64. doi: 10.1016/0002-9378(83)90927-4.
10
Methotrexate-resistant mechanisms in human choriocarcinoma cells.人绒毛膜癌细胞中的甲氨蝶呤耐药机制。
Gynecol Oncol. 1989 Jul;34(1):7-11. doi: 10.1016/0090-8258(89)90095-4.